Topics and Expertise: Chemical Biology

Scientists in the UCSF School of Pharmacy recently identified the first drug-binding target site on a molecule known to play a role in Parkinson's disease, opening the door to a new generation of therapies for the condition.

The next frontier in developing therapies for cancer and other diseases could come through studying organ development or tumor growth in living humans. Problem is, there’s no ethical way of doing that using current technology.

Zev Gartner, PhD, has focused on the next best thing: His lab is...

James Wells, PhD, chair of the School’s Department of Pharmaceutical Chemistry, has been elected as a member of the 2015 class of the American Academy of Arts and Sciences.

Professor

My research focuses on discovering and characterizing novel small molecules that can control stem cell maintenance, activation, differentiation, and reprogramming in various tissue types.

Professor

My research focuses on developing enabling technologies for protein engineering and drug discovery to understand biology and pave roads to therapeutics.

Professor

My laboratory is working to understand how cells self-organize into tissues, how the structure of tissues help regulate cell behaviors, and how tissue structure breaks down in diseases like cancer. By understanding these processes we hope to reveal general principles contributing to cancer...

Professor

I focus on defining the roles and the mechanisms of enzymes in complex biological processes and on developing technologies to facilitate these studies to aid in the rapid detection, monitoring, and control of infectious disease and cancer.

Danica Galonić Fujimori, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine has been named a 2011 Searle Scholar. Her UCSF School of Pharmacy faculty colleague, Bo Huang, PhD, earned the honor in 2010.